317450 Stock Chart & Stats
₩40800.00
-₩2,000.00(-4.67%)
―
--
Day’s Range― - ―
52-Week Range₩39,100.00 - ₩134,500.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)19.19K
Market Cap
₩624.88B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.3
Beta0.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,600,000
10 Day Avg. Volume13,196
30 Day Avg. Volume19,188
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6,058
Revenue Forecast (FY)₩321.40B
317450 FAQ
What was Myung in Pharm Co., Ltd.’s price range in the past 12 months?
Myung in Pharm Co., Ltd. lowest stock price was ₩39100.00 and its highest was ₩134500.00 in the past 12 months.
What is Myung in Pharm Co., Ltd.’s market cap?
Myung in Pharm Co., Ltd.’s market cap is ₩624.88B.
When is Myung in Pharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Myung in Pharm Co., Ltd.’s earnings last quarter?
Myung in Pharm Co., Ltd. released its earnings results on Mar 18, 2026. The company reported ₩1592.66 earnings per share for the quarter, beating the consensus estimate of N/A by ₩1592.66.
Is Myung in Pharm Co., Ltd. overvalued?
According to Wall Street analysts Myung in Pharm Co., Ltd.’s price is currently Undervalued.
Does Myung in Pharm Co., Ltd. pay dividends?
Myung in Pharm Co., Ltd. does not currently pay dividends.
What is Myung in Pharm Co., Ltd.’s EPS estimate?
Myung in Pharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Myung in Pharm Co., Ltd. have?
Myung in Pharm Co., Ltd. has 14,600,000 shares outstanding.
What happened to Myung in Pharm Co., Ltd.’s price movement after its last earnings report?
Myung in Pharm Co., Ltd. reported an EPS of ₩1592.66 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.335%.
Which hedge fund is a major shareholder of Myung in Pharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:317450
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JW Pharmaceutical Corporation
―
Daewoong Co., Ltd.
―
Boryung Corporation
―
Pharmicell Co., Ltd
―
Medy-Tox Inc.
―